Dose-Escalation Study of Stereotactic Body Radiation Therapy (SBRT) for Peripheral T2N0M0 Non-Small Cell Lung Cancer (NSCLC) With PTV ≥ 100 cm3: Japan Clinical Oncology Group Study (JCOG0702)

被引：1
|
作者：
Onishi, H. [1 ]
Onimaru, R. [2 ]
Shibata, T. [3 ]
Hiraoka, M. [4 ]
Ishikura, S. [5 ]
Karasawa, K. [6 ]
Matsuo, Y. [4 ]
Kokubo, M. [7 ,8 ]
Shioyama, Y. [9 ]
Matsushita, H. [10 ]
Ito, Y. [11 ]
Shirato, H. [2 ]
机构：
[1] Univ Yamanashi, Kofu, Yamanashi, Japan
[2] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan
[3] Natl Canc Ctr, Ctr Res Adm & Support, Tokyo 104, Japan
[4] Kyoto Univ, Grad Sch Med, Kyoto 6068507, Japan
[5] Koshigaya Municipal Hosp, Koshigaya, Japan
[6] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
[7] Inst Biomed Res, Kobe, Hyogo, Japan
[8] Innovat Hosp, Kobe, Hyogo, Japan
[9] SAGA HIMAT Fdn, Ion Beam Therapy Ctr, Saga, Japan
[10] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan
[11] Natl Canc Ctr, Tokyo, Japan
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.244
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
231
引用
收藏
页码：S102 / S102
页数：1
相关论文
共 50 条
  • [41] Stereotactic body radiotherapy for primary non-small cell lung cancer patients with clinical T3-4N0M0 (UICC 8th edition): outcomes and patterns of failure
    Narita, Atsuya
    Takeda, Atsuya
    Eriguchi, Takahisa
    Saigusa, Yusuke
    Sanuki, Naoko
    Tsurugai, Yuichiro
    Enomoto, Tatsuji
    Kuribayashi, Hidehiko
    Mizuno, Tomikazu
    Yashiro, Kae
    Hara, Yu
    Kaneko, Takeshi
    JOURNAL OF RADIATION RESEARCH, 2019, 60 (05) : 639 - 649
  • [42] Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis
    Li, Ming
    Yang, Xiaodong
    Chen, Yuhan
    Yang, Xinyu
    Dai, Xiyu
    Sun, Fenghao
    Zhang, Li
    Zhan, Cheng
    Feng, Mingxiang
    Wang, Qun
    ONCOTARGETS AND THERAPY, 2017, 10 : 2885 - 2892
  • [43] In response to Komiya T et al. "Addition of chemotherapy improves overall survival in patients with T2N0M0 non-small cell lung cancer undergoing definitive radiation therapy: An analysis of the SEER database"
    Hsia, Te-Chun
    Tu, Chih-Yen
    Li, Chia-Chin
    Chien, Chun-Ru
    RADIOTHERAPY AND ONCOLOGY, 2019, 135 : 199 - 199
  • [44] Comparison of the outcomes of sublobar resection and stereotactic body radiotherapy for stage T1-2N0M0 non-small cell lung cancer with tumor size ≤ 5 cm: a propensity score matching analysis
    Dong, Baiqiang
    Zhu, Xuan
    Jin, Jianan
    Chen, Yuanyuan
    Ying, Hangjie
    Chen, Yamei
    Lu, Fangxiao
    Shen, Wei
    Wang, Jin
    Chen, Ming
    JOURNAL OF THORACIC DISEASE, 2020, 12 (10) : 5934 - 5944
  • [45] GRECO-1: Phase 1/2 Study of Stereotactic Body Radiation Therapy (SBRT) with or without Rucosopasem (GC4711) for Early Stage, Peripheral or Centrally Located Non-Small Cell Lung Cancer (NSCLC)
    Iyengar, P.
    Allen, B. G.
    Kelsey, C. R.
    Moser, E. C.
    Holm, M.
    Kurman, M.
    Holmlund, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E375 - E376
  • [46] Comparative efficacy and toxicity of induction chemotherapy with concurrent stereotactic body radiotherapy and stereotactic body radiotherapy with subsequent chemotherapy in patients with clinical stage T1-3N0M0 non-small cell lung carcinoma
    Sun, Y.
    Duan, Q.
    Chen, X.
    Chen, W.
    Jin, X.
    Wu, R.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (12): : 1498 - 1506
  • [47] Comparative efficacy and toxicity of induction chemotherapy with concurrent stereotactic body radiotherapy and stereotactic body radiotherapy with subsequent chemotherapy in patients with clinical stage T1-3N0M0 non-small cell lung carcinoma
    Y. Sun
    Q. Duan
    X. Chen
    W. Chen
    X. Jin
    R. Wu
    Clinical and Translational Oncology, 2017, 19 : 1498 - 1506
  • [48] In response to Hsia TC et al. "Addition of chemotherapy improves overall survival in patients with T2N0M0 non-small cell lung cancer undergoing definitive radiation therapy: An analysis of the SEER database"
    Komiya, Takefumi
    Chaaya, Gerard
    Powell, Emily
    RADIOTHERAPY AND ONCOLOGY, 2019, 135 : 200 - 200
  • [49] EGFR-TKIs plus stereotactic body radiation therapy (SBRT) for stage IV Non-small cell lung cancer (NSCLC): A prospective, multicenter, randomized, controlled phase II study
    Peng, Ping
    Gong, Juejun
    Zhang, Yujie
    Zhou, Shuchang
    Li, Yichen
    Han, Guang
    Meng, Rui
    Chen, Yongshun
    Yang, Ming
    Shen, Qian
    Chu, Qian
    Xia, Shu
    Zhang, Peng
    Zhang, Lu
    Chen, Yuan
    Zhang, Li
    RADIOTHERAPY AND ONCOLOGY, 2023, 184
  • [50] Results of a multi-institutional, randomized, non-inferiority, phase III trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer: Japan Clinical Oncology Group Study JCOG0701)
    Kodaira, T.
    Kagami, Y.
    Shibata, T.
    Shikama, N.
    Nishimura, Y.
    Ishikura, S.
    Nakamura, K.
    Saito, Y.
    Matsumoto, Y.
    Teshima, T.
    Ito, Y.
    Akimoto, T.
    Nakata, K.
    Toshiyasu, T.
    Nakagawa, K.
    Nagata, Y.
    Nishimura, T.
    Uno, T.
    Kataoka, M.
    Yorozu, A.
    Hiraoka, M.
    ANNALS OF ONCOLOGY, 2018, 29 (04) : 992 - 997
12345